Head of Product Development
Cybernax Bio
NORTHVALE, New Jersey
Pengbo Guo is a seasoned executive specializing in drug delivery systems, RNA-LNP technology, and drug development. He currently serves as Head of Product Development at CybernaX Biotechnologies, where he leads the advancement of next-generation nucleic acid delivery platforms targeting vaccines, gene editing, protein replacement therapies, and inhalable LNP formulations.
Prior to CybernaX, Dr. Guo was with Pfizer’s Vaccine R&D division, focusing on preclinical LNP formulation and process development. He contributed to mRNA programs for COVID-19, RSV, and influenza, advancing multiple candidates into IND-enabling studies. Earlier in his career, he gained deep experience in clinical-stage product development and CTM GMP manufacturing.
In addition to his technical leadership, Dr. Guo oversees global business development at CybernaX, driving partnerships and licensing efforts.
Dr. Guo holds a Ph.D. in Pharmaceutical Sciences. His work bridges scientific innovation and commercial strategy to accelerate RNA-based therapeutics toward clinical and market success.
Disclosure information not submitted.
Symposium: Enabling Technologies and Materials for Formulation Innovation 2
Tuesday, November 11, 2025
9:00 AM - 11:00 AM CT